These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 25374303)
1. Magnetic resonance imaging of post-ischemic blood-brain barrier damage with PEGylated iron oxide nanoparticles. Liu DF; Qian C; An YL; Chang D; Ju SH; Teng GJ Nanoscale; 2014 Dec; 6(24):15161-7. PubMed ID: 25374303 [TBL] [Abstract][Full Text] [Related]
2. Comparison of USPIO-enhanced MRI and Gd-DTPA enhancement during the subacute stage of focal cerebral ischemia in rats. Yang YM; Feng X; Yin le K; Li CC; Jia J; Du ZG Acta Radiol; 2014 Sep; 55(7):864-73. PubMed ID: 24065200 [TBL] [Abstract][Full Text] [Related]
3. Influence of Surface Charge and Polymer Coating on Internalization and Biodistribution of Polyethylene Glycol-Modified Iron Oxide Nanoparticles. Maurizi L; Papa AL; Dumont L; Bouyer F; Walker P; Vandroux D; Millot N J Biomed Nanotechnol; 2015 Jan; 11(1):126-36. PubMed ID: 26301306 [TBL] [Abstract][Full Text] [Related]
4. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement. Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of pseudopolyrotaxanes-coated Superparamagnetic Iron Oxide Nanoparticles as new MRI contrast agent. Hosseini F; Panahifar A; Adeli M; Amiri H; Lascialfari A; Orsini F; Doschak MR; Mahmoudi M Colloids Surf B Biointerfaces; 2013 Mar; 103():652-7. PubMed ID: 23199519 [TBL] [Abstract][Full Text] [Related]
6. Simultaneous evaluation of vascular morphology, blood volume and transvascular permeability using SPION-based, dual-contrast MRI: imaging optimization and feasibility test. Kwon HJ; Shim WH; Cho G; Cho HJ; Jung HS; Lee CK; Lee YS; Baek JH; Kim EJ; Suh JY; Sung YS; Woo DC; Kim YR; Kim JK NMR Biomed; 2015 Jun; 28(6):624-32. PubMed ID: 25865029 [TBL] [Abstract][Full Text] [Related]
7. Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION-EGF) for targeting brain tumors. Shevtsov MA; Nikolaev BP; Yakovleva LY; Marchenko YY; Dobrodumov AV; Mikhrina AL; Martynova MG; Bystrova OA; Yakovenko IV; Ischenko AM Int J Nanomedicine; 2014; 9():273-87. PubMed ID: 24421639 [TBL] [Abstract][Full Text] [Related]
8. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice. Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000 [TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid conjugated superparamagnetic iron oxide nanoparticle for cancer diagnosis and hyperthermia therapy. Thomas RG; Moon MJ; Lee H; Sasikala AR; Kim CS; Park IK; Jeong YY Carbohydr Polym; 2015 Oct; 131():439-46. PubMed ID: 26256205 [TBL] [Abstract][Full Text] [Related]
10. Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging. Hu F; Jia Q; Li Y; Gao M Nanotechnology; 2011 Jun; 22(24):245604. PubMed ID: 21508500 [TBL] [Abstract][Full Text] [Related]
11. Magnetic Enhancement of Stem Cell-Targeted Delivery into the Brain Following MR-Guided Focused Ultrasound for Opening the Blood-Brain Barrier. Shen WB; Anastasiadis P; Nguyen B; Yarnell D; Yarowsky PJ; Frenkel V; Fishman PS Cell Transplant; 2017 Jul; 26(7):1235-1246. PubMed ID: 28933214 [TBL] [Abstract][Full Text] [Related]
12. Evaluating size-dependent relaxivity of PEGylated-USPIOs to develop gadolinium-free T1 contrast agents for vascular imaging. Khandhar AP; Wilson GJ; Kaul MG; Salamon J; Jung C; Krishnan KM J Biomed Mater Res A; 2018 Sep; 106(9):2440-2447. PubMed ID: 29664208 [TBL] [Abstract][Full Text] [Related]
13. Step-down infusions of Gd-DTPA yield greater contrast-enhanced magnetic resonance images of BBB damage in acute stroke than bolus injections. Nagaraja TN; Nagesh V; Ewing JR; Whitton PA; Fenstermacher JD; Knight RA Magn Reson Imaging; 2007 Apr; 25(3):311-8. PubMed ID: 17371719 [TBL] [Abstract][Full Text] [Related]
15. Identification of variations in blood-brain barrier opening after cerebral ischemia by dual contrast-enhanced magnetic resonance imaging and T 1sat measurements. Nagaraja TN; Karki K; Ewing JR; Croxen RL; Knight RA Stroke; 2008 Feb; 39(2):427-32. PubMed ID: 18174480 [TBL] [Abstract][Full Text] [Related]
16. Thermosensitive/superparamagnetic iron oxide nanoparticle-loaded nanocapsule hydrogels for multiple cancer hyperthermia. Zhang ZQ; Song SC Biomaterials; 2016 Nov; 106():13-23. PubMed ID: 27543919 [TBL] [Abstract][Full Text] [Related]
17. Folate-PEG-superparamagnetic iron oxide nanoparticles for lung cancer imaging. Yoo MK; Park IK; Lim HT; Lee SJ; Jiang HL; Kim YK; Choi YJ; Cho MH; Cho CS Acta Biomater; 2012 Aug; 8(8):3005-13. PubMed ID: 22543005 [TBL] [Abstract][Full Text] [Related]
18. Crucial role of the protein corona for the specific targeting of nanoparticles. Mahmoudi M; Sheibani S; Milani AS; Rezaee F; Gauberti M; Dinarvand R; Vali H Nanomedicine (Lond); 2015 Jan; 10(2):215-26. PubMed ID: 25600967 [TBL] [Abstract][Full Text] [Related]
19. Difference in the intratumoral distributions of extracellular-fluid and intravascular MR contrast agents in glioblastoma growth. Kim JH; Suh JY; Woo DC; Sung YS; Son WC; Choi YS; Pae SJ; Kim JK NMR Biomed; 2016 Dec; 29(12):1688-1699. PubMed ID: 27723161 [TBL] [Abstract][Full Text] [Related]
20. Effect of surface coating on the biocompatibility and in vivo MRI detection of iron oxide nanoparticles after intrapulmonary administration. Al Faraj A; Shaik AP; Shaik AS Nanotoxicology; 2015; 9(7):825-34. PubMed ID: 26356541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]